Immediate Impact
1 from Science/Nature 51 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Works of Jianping Bi being referenced
A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?
2016
Correlation of bevacizumab-induced hypertension and outcomes of metastatic colorectal cancer patients treated with bevacizumab: a systematic review and meta-analysis
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jianping Bi | 205 | 153 | 180 | 52 | 529 | |
| Chunyan Li | 203 | 137 | 221 | 63 | 633 | |
| Yanying Li | 237 | 200 | 171 | 55 | 636 | |
| Xixu Zhu | 111 | 228 | 187 | 30 | 528 | |
| Jiaqi Li | 122 | 200 | 133 | 40 | 615 | |
| N. Lee | 138 | 110 | 139 | 51 | 548 | |
| Dwight R. Stickney | 96 | 93 | 172 | 40 | 633 | |
| Jun Xue | 71 | 118 | 182 | 45 | 635 | |
| Yu‐Sen Huang | 100 | 150 | 101 | 55 | 583 | |
| Jane C. Wright | 210 | 91 | 142 | 42 | 484 | |
| Yu Peng | 230 | 144 | 228 | 37 | 540 |
All Works
Login with ORCID to disown or claim papers
Loading papers...